poisar

Stocks · News reference

Correction: UBS Maintains Buy on Teradyne, Raises Price Target to $500

BenzingaJul 20, 2026, 6:26 PMBenzinga Newsdesk

Correction: UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $440 to $500.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 20, 2026, 6:26 PM
Checked
Jul 20, 2026, 6:26 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading